<VariationArchive VariationID="2427392" VariationName="NC_000001.10:g.(?_235616382)_(235643485_?)del" VariationType="Deletion" Accession="VCV002427392" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1950168" VariationID="2427392">
      <GeneList>
        <Gene Symbol="B3GALNT2" FullName="beta-1,3-N-acetylgalactosaminyltransferase 2" GeneID="148789" HGNC_ID="HGNC:28596" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235439796" stop="235504452" display_start="235439796" display_stop="235504452" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_014040927.1" start="83388" stop="148044" display_start="83388" display_stop="148044" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235610532" stop="235667780" display_start="235610532" display_stop="235667780" Strand="-" />
          </Location>
          <OMIM>610194</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000001.10:g.(?_235616382)_(235643485_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q42.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="235616382" innerStop="235643485" display_start="235616382" display_stop="235643485" variantLength="27104" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_235616382)_(235643485_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_235616382)_(235643485_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.10:g.(?_235616382)_(235643485_?)del AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" Accession="RCV003113721" Version="3">
        <ClassifiedConditionList TraitSetID="9507">
          <ClassifiedCondition DB="MedGen" ID="C3554638">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24084573</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25326637</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29273094</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33290285</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9507" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17747" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ElementValue>
                <XRef ID="MONDO:0014071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GALNT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGA11</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15915" />
                <XRef ID="15915" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3554638" DB="MedGen" />
              <XRef ID="MONDO:0014071" DB="MONDO" />
              <XRef Type="MIM" ID="615181" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7076398" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_152490.4_1_Deletion (exons 5-11)|MedGen:C3554638" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003796803" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24084573</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25326637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29273094</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33290285</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 5-11 of the B3GALNT2 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the B3GALNT2 protein in which other variant(s) (p.Asp327Asn) have been determined to be pathogenic (PMID: 24084573, 25326637, 29273094, 33290285). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with B3GALNT2-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="B3GALNT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_235616382)_(235643485_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554638" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7076398" TraitType="Disease" MappingType="XRef" MappingValue="C3554638" MappingRef="MedGen">
        <MedGen CUI="C3554638" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

